Cancer Immunotherapy – Is It Really a “Game-Changer”?
Traditionally, cancer is treated by surgery, chemotherapy or radiotherapy. However, some of the most exciting breakthroughs are now being made using another type of treatment called immunotherapy. This treatment is well established in other medical conditions such as rheumatoid arthritis and allergic asthma. Numerous sources now declare immunotherapy to be a “game-changer” in cancer treatment and we will discuss that here.
Screening and Non-Small-Cell Lung Cancer
This article reviews key advances in the management of non-small-cell lung cancer and the clinical gains in outcomes as well as the ability to deliver personalized cancer treatment.
Unexpected Brain MRI Findings - A Headache You Didn’t Know You Had
Incidental findings from brain magnetic resonance imaging (MRI) that need further evaluation occur in about 3% of middle-aged and elderly populations - that’s one for every 37 scans.
Sepsis Mortality and Morbidity Trends – An Insurance Perspective
RGA’s Dr. Daniel Zimmerman answers questions on sepsis development and mortality trends.
Antimicrobial Resistance – Taking Stock
A recent UK report estimated that, in the absence of any progress in combating antimicrobial resistance, there would be a staggering 10,000,000 deaths globally in 2050, compared to 700,000 today. To provide some perspective for this number, antimicrobial resistance would cause more deaths than cancer. The economic cost would be US$100 trillion. The implications for the insurance industry are potentially very damaging.
The Significance of Hemoglobin A1C Levels in Nondiabetics (Munich RE)
It has been demonstrated that the development of microvascular complications of diabetes mellitus, especially diabetic retinopathy, can be delayed by establishing more strict glycemic control. As a result, methods of monitoring glycemic control by measuring the amount of glucose attached to various proteins in the blood have been developed.
Advances in Cancer Research and Insurance
The International Agency for Research on Cancer (IARC) was created more than 50 years ago to foster global collaboration on cancer control. Today more effective therapies mean mortality rates no longer reflect incidence rates; there are now more cancer survivors partly due to advances that enable early diagnosis.
Breast Cancer in Women (SCOR inFORM)
Breast cancer in women is a real public health issue. All doctors, whatever their specialty, are confronted to some extent with patients with this type of tumor. It is the second most common type of cancer in the world. Breast cancer is responsible for more than 520,000 deaths each year, and is the fifth most frequent cause of death in the world.
How 3D Printing Is Changing Medical Treatment
It’s not so surprising that solid objects made from printed plastic or titanium, such as replacement hip joints or dental implants, can be made by 3D printers. More remarkable is that new human tissue might be printed from bio-ink comprising of droplets of living cells, stem cells and other biomaterials to replace or support an existing biological structure - a process known as regenerative medicine.
Insurers in Quest of the Perfect Heart Attack Definition
Insurers should be concerned when challenged to use the clinical definition of a heart attack. There is more to a diagnosis than the definition. Navigating the conflict between clinical medicine and a contract wording is complex but can be solved.